<DOC>
	<DOCNO>NCT00517504</DOCNO>
	<brief_summary>The purpose study determine methylphenidate ( common brand name Ritalin ) , medicine use treat old child Attention Deficit Hyperactivity Disorder ( ADHD ) , also safe helpful problem relate symptom ADHD young child Developmental Disorders ( DD )</brief_summary>
	<brief_title>Methylphenidate Study Young Children With Developmental Disorders</brief_title>
	<detailed_description>Currently , systematic empirical information guide use methylphenidate ( common brand name Ritalin ) treat symptom ADHD young child Autistic Disorder/Asperger 's Disorder/Pervasive Developmental Disorder , Not Otherwise Specified/Developmental Disorders . Preliminary data recent study ADHD young child suggest methylphenidate may useful child developmental disorder ( DD ) . The purpose study determine safety efficacy methylphenidate treat ADHD symptom young child Pervasive Developmental Disorders ( PDD ) Developmental Disorders ( DD ) . All subject screen eligibility inclusion exclusion criterion . All concurrent non-pharmacological therapy stabilize minimum period 2 week prior child 's entry drug phase study . At medication follow-up visit , detailed history obtain record concurrent treatment . If child enrolls study , his/her participation last approximately 3 4Â½ month 12-18 outpatient daytime visit . Screening assessment : The child 's parent teacher/daycare provider , applicable , need complete form describe child 's problem overactivity , impulsivity inattention . If form indicate child may ADHD investigator schedule outpatient-screening assessment . The research staff evaluate child see s/he Developmental Disorder ( DD ) PDD ADHD . Each child receive developmental assessment , parent interview child 's behavior . The child 's teacher give several rating form complete . The parent ask complete question child 's development . Both parent ( available ) interview family history . Some screening assessment videotaped/audiotaped . Each child physical examination , electrocardiogram ( EKG ) , urine test blood test . The doctor ask parent child 's medical history . Medication phase : After screen assessment complete , child enter medication phase study . Each child first step-wise single-blind titration MPH determine his/her best dose follow double-blind crossover trial placebo child 's best dose . The order active drug placebo randomize across sample half child first receive MPH 2 week half first receive placebo 2 week . The child receive alternative drug condition ( placebo child 's best dose ) next 2 week . The child his/her parent come back week clinic visit . At visit child 's height , weight , blood pressure pulse check . The child 's parent teacher/daycare provider , applicable , ask complete rating scale every week .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Developmental Disabilities</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>3684 month old child Child must meet DSMIV criterion AD PDD NOS determine via parent interview ADIR child observation via ADOS , DD . Child must categorical dimensional evidence clinically significant ADHD symptom multiple setting present least six month Child prior fail treatment adequate trial methylphenidate ; Concurrent treatment medication CNS effect affect performance ( e.g. , antidepressant , antipsychotic , alphaagonists , adrenergic blocker , lithium carbonate , sedate antihistamine , decongestant sympathomimetics ) ; Child current history chronic tic disorder ( e.g. , Tourette syndrome current severity moderate ) , family history Tourette 's Disorder . Children chronic mild tic eligible study ; Child major medical condition would interfere involvement study would affect negatively methylphenidate ( i.e. , heart disease , high blood pressure , glaucoma , untreated unstable hyperthyroidism , uncontrolled seizure disorder , illness would require hospitalization ) . Children seizures eligible study seizure medication stable 3 month child seizurefree least 6 month ; Child comorbid psychiatric diagnosis Major Depression , Bipolar Disorder , psychotic disorder , Rett 's Disorder , Childhood Disintegrative Disorder , psychiatric disorder addition PDD ADHD may require treatment additional/alternative medication ; Current history physical , sexual , emotional abuse ; The patient take investigational drug within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>36 Months</minimum_age>
	<maximum_age>84 Months</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>methylphenidate</keyword>
	<keyword>ritalin</keyword>
	<keyword>attention deficit hyperactivity disorder</keyword>
	<keyword>developmental disorder</keyword>
	<keyword>preschool child</keyword>
</DOC>